Sign In
Buy FIXX
$0.93
+0 (+0%)
At Close: Jun 24, 2024
Homology Medicines (NASDAQ:FIXX) Stock Rating Lowered by Zacks Investment Research
07:02am, Friday, 27'th Mar 2020
Homology Medicines (NASDAQ:FIXX) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued on Wednesday, Zacks.com reports. According to Za
Selloff creating bargains in healthcare - Baird
05:54pm, Wednesday, 25'th Mar 2020
Stating the obvious, Baird analysts have created three lists of healthcare companies that may be worth a look considering their attractive valuations or relatively strong capitalizations amid the COVI
Homology Medicines (NASDAQ:FIXX) Shares Up 10.6%
09:50am, Tuesday, 24'th Mar 2020
Homology Medicines Inc (NASDAQ:FIXX)’s stock price traded up 10.6% during mid-day trading on Monday . The company traded as high as $15.27 and last traded at $15.18, 231,389 shares changed hands dur
ProShare Advisors LLC Sells 1,841 Shares of Homology Medicines Inc (NASDAQ:FIXX)
09:04am, Tuesday, 24'th Mar 2020
ProShare Advisors LLC reduced its position in Homology Medicines Inc (NASDAQ:FIXX) by 12.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange
ProMetic Life Sciences (OTCMKTS:PFSCF) and Homology Medicines (OTCMKTS:FIXX) Financial Review
05:18am, Friday, 20'th Mar 2020
ProMetic Life Sciences (OTCMKTS:PFSCF) and Homology Medicines (NASDAQ:FIXX) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the stren
Homology Medicines Inc (NASDAQ:FIXX) Expected to Announce Earnings of -$0.76 Per Share
12:24pm, Wednesday, 18'th Mar 2020
Wall Street brokerages predict that Homology Medicines Inc (NASDAQ:FIXX) will post earnings per share (EPS) of ($0.78) for the current fiscal quarter, Zacks reports. Two analysts have provided estimat
Charles Schwab Investment Management Inc. Acquires 2,716 Shares of Homology Medicines Inc (NASDAQ:FIXX)
08:26am, Tuesday, 17'th Mar 2020
Charles Schwab Investment Management Inc. lifted its holdings in Homology Medicines Inc (NASDAQ:FIXX) by 1.8% in the fourth quarter, Holdings Channel reports. The fund owned 151,504 shares of the comp
Homology Medicines Inc (NASDAQ:FIXX) Expected to Post Quarterly Sales of $650,000.00
06:26am, Tuesday, 17'th Mar 2020
Wall Street analysts expect that Homology Medicines Inc (NASDAQ:FIXX) will post $650,000.00 in sales for the current quarter, Zacks Investment Research reports. Two analysts have provided estimates fo
BRIEF-Homology Medicines Announces Peer-Reviewed Publication Of HMI-102 Investigational Gene Therapy
01:28pm, Monday, 16'th Mar 2020
Homology Medicines Inc:
Homology Medicines, Inc. (FIXX), a genetic medicines company, announced today the peer-reviewed publication of preclinical data that supports Homology’s HMI-102 investigational gene therapy program
Homology Medicines (NASDAQ:FIXX) Upgraded by Oppenheimer to "Buy"
07:12am, Monday, 16'th Mar 2020
Homology Medicines (NASDAQ:FIXX) was upgraded by stock analysts at Oppenheimer to a “buy” rating in a note issued to investors on Sunday, TipRanks reports. The firm currently has a $32.00 price ta
What Made Oppenheimer Upgrade Homology Medicines’ Stock?
12:36am, Monday, 16'th Mar 2020
In a report released yesterday, Matthew Biegler from Oppenheimer upgraded Homology Medicines (FIXX – Research Report) to Buy, with a
Homology Medicines Inc (NASDAQ:FIXX) Shares Bought by Barclays PLC
08:58am, Sunday, 15'th Mar 2020
Barclays PLC raised its position in Homology Medicines Inc (NASDAQ:FIXX) by 75.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm
Homology Medicines, Inc. Analysts Are Cutting Their Estimates: Here's What You Need To Know
01:14pm, Saturday, 14'th Mar 2020
One of the biggest stories of last week was how Homology Medicines, Inc. (NASDAQ:FIXX) shares plunged 28% in the week...
Earnings Update: Homology Medicines, Inc. Just Reported And Analysts Are Trimming Their Forecasts
01:13pm, Saturday, 14'th Mar 2020
There's been a major selloff in Homology Medicines, Inc. (NASDAQ:FIXX) shares in the week since it released its yearly...
